Stereotactic Body Radiation Therapy Plus Chemotherapy Improves Survival Among Stage 4 Lung Cancer Patients

A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, scientists report.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1ydXBVD